Five-year denosumab treatment of postmenopausalwomen with osteoporosis: results of the first twoyears of the freedom trial extension.
https://doi.org/10.14341/osteo2011140-40
About the Authors
S PapapoulosZ Man
D Mellstrom
S Radominski
J-Y Reginster
H Resch
J Roman
S Roux
S Cummings
H Bone
R Chapurlar
M Brandi
J Brown
E Czerwinski
N Daizadeh
A Grauer
M-A Krieg
S Libanati
Review
For citations:
Papapoulos S., Man Z., Mellstrom D., Radominski S., Reginster J., Resch H., Roman J., Roux S., Cummings S., Bone H., Chapurlar R., Brandi M., Brown J., Czerwinski E., Daizadeh N., Grauer A., Krieg M., Libanati S. Five-year denosumab treatment of postmenopausalwomen with osteoporosis: results of the first twoyears of the freedom trial extension. Osteoporosis and Bone Diseases. 2011;14(1):40-40. (In Russ.) https://doi.org/10.14341/osteo2011140-40

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).